Related Experiment Videos
Quantitative morphometric analysis of the microcirculation in prostate carcinoma.
M K Brawer1, S A Bigler, R E Deering
1Department of Urology, Seattle Veterans Administration Medical Center, Washington.
Journal of Cellular Biochemistry. Supplement
|January 1, 1992
Summary
Prostatic carcinoma exhibits significantly higher microvessel density compared to benign tissue. This increased vascularity correlates with advanced pathologic stage, suggesting its potential as a prognostic indicator for prostate cancer.
Area of Science:
- Oncology
- Pathology
- Urology
Background:
- Neoplasms often induce capillary neovascularization, potentially indicating aggressive behavior.
- Neovascularity plays a crucial role in tumor growth and metastasis.
- Understanding vascular patterns in prostate tissue is vital for diagnosis and prognosis.
Purpose of the Study:
- To investigate and quantify neovascularity in benign and malignant prostate tissue.
- To compare microvessel density between cancerous and normal prostatic tissue.
- To explore the correlation between microvessel density and the pathologic stage of prostate cancer.
Main Methods:
- Immunohistochemical visualization of microvessel profiles using Factor VIII antibodies.
- Quantification of microvessel density via computerized image analysis (Optimas system).
- Comparison of microvessel density in benign and malignant portions of radical prostatectomy specimens.
Main Results:
- Significantly higher vascular density was observed in cancerous prostate tissue compared to benign tissue (ratio = 2.02, p < 0.001).
- Microvessel distribution was random in malignancy versus periglandular in benign tissue.
- Increased microvessel density correlated with advanced pathologic stage, with higher densities found in more advanced cancers.
Conclusions:
- Prostatic carcinoma demonstrates increased vascularity relative to benign tissue.
- Microvessel density is correlated with the pathologic stage of prostate cancer.
- Microvessel density shows potential as a prognostic indicator for prostate cancer.